)
Trisalus Life Sciences (TLSI) investor relations material
Trisalus Life Sciences Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Voting matters and shareholder proposals
Election of two director nominees, Mary Szela and Gary Gordon, to serve until the 2029 Annual Meeting or until earlier departure.
Ratification of Grant Thornton LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.
Advisory vote on the frequency of future stockholder advisory votes on executive compensation, with a recommendation for every three years.
Advisory vote on the compensation of named executive officers.
Provision for other business to be addressed as may properly come before the meeting or any adjournment.
Board of directors and corporate governance
Two nominees, Mary Szela and Gary Gordon, are recommended for election to the board.
Audit committee and external auditor matters
Grant Thornton LLP is recommended for ratification as the independent registered public accounting firm for the upcoming fiscal year.
- Proxy covers director elections, auditor ratification, and executive compensation votes.TLSI
Proxy filing31 Mar 2026 - Strong revenue growth, expanded product suite, and robust 2026 outlook with $46M new capital.TLSI
Q4 20255 Mar 2026 - Q2 revenue up 60% to $7.4M, gross margin at 88%, net loss narrowed to $4.3M.TLSI
Q2 20241 Feb 2026 - Rapid growth in drug delivery tech, new clinical data, and EBITDA positive targeted for 2025.TLSI
Maxim Group’s 2024 Healthcare Virtual Summit19 Jan 2026 - Q3 revenue up 42% year-over-year; 2025 outlook targets 50%+ growth and positive EBITDA.TLSI
Q3 202414 Jan 2026 - 2024 revenue up 59% to $29.4M; 2025 outlook targets 50%+ growth and positive EBITDA.TLSI
Q4 202426 Dec 2025 - Resale of 10.6M shares by holders may impact stock volatility; no proceeds to the company.TLSI
Registration Filing16 Dec 2025 - Registration allows OrbiMed to resell 91,263 warrant shares; no resale proceeds to the company.TLSI
Registration Filing16 Dec 2025 - $22M private placement shares registered for resale; no proceeds to company; oncology focus.TLSI
Registration Filing16 Dec 2025
Next Trisalus Life Sciences earnings date
Next Trisalus Life Sciences earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)